Spilanthes acmella for Skin Rejuvenation - Quick Reference Sheet

Spilanthes acmella for Skin Rejuvenation

Created on 09/28/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Spilanthes acmella is a tingling, numbing tropical herb whose flower extract is sold as a skin-care ingredient for smoothing facial lines. Small human studies point to modest, gradual gains in fine lines, skin moisture and texture over a few weeks; an injection-like wrinkle-relaxing effect was not borne out in people. Evidence is thin, mostly company-run. Main concerns are tingling and possible daisy-family plant allergy; otherwise low-risk, with modest, uncertain benefits. (Full Review)

Protocol

Standard topical regimen
Once or twice daily
Serum or cream with Acmella oleracea flower extract on clean skin around the eyes, mouth and forehead; published studies ran 2–8 weeks
Concentration
0.1–10% dry extract
Or 0.05–5% pure spilanthol per the originator patent; example formulas at 1–2%; most retail products do not disclose concentration
Pre-existing conditions
Patch test, then every other day
Rosacea, eczema or recent procedures: slower start of every other day for the first week
Time to effect
Fine lines and wrinkles
2 weeks
Gradual reduction around the eyes and mouth in serum trials
Hydration and smoothness
Within 2 weeks
Skin moisture and texture changes in trials
Firmness
6–8 weeks
Measured in multi-ingredient products

Benefits

Contraindications
  • People with a positive patch test to sesquiterpene lactone mix or Compositae mix, or prior reactions to chamomile, arnica or ragweed
  • Pregnant or breastfeeding individuals (oral use)
  • Men with androgen-sensitive prostate cancer on antiandrogen therapy (oral use)
  • Active eczema, open wounds or skin within 7–14 days of ablative (skin-removing) laser, medium-depth peel or microneedling
Key Interactions
  • Topical prescription retinoids (tretinoin, adapalene, tazarotene)
  • Potent prescription topicals (clobetasol, hydroquinone)
  • Over-the-counter exfoliants and retinol (glycolic acid, salicylic acid, retinol serums)
  • Over-the-counter topical anesthetics (lidocaine, benzocaine)
  • Daisy-family botanicals (chamomile, arnica, calendula, echinacea)
  • Other tingling alkylamide extracts (Sichuan pepper, echinacea)
  • Diuretics (furosemide, hydrochlorothiazide), oral Acmella only
  • Drugs broken down by the liver enzyme CYP2E1 (chlorzoxazone, isoflurane, sevoflurane), theoretical

Risk & Side Effects

  • High:
  • Medium: Tingling, numbness and taste disturbance
  • Low: Allergic contact dermatitis in daisy-family allergy; painful lip swelling
  • Speculative: Increased skin uptake of co-applied substances; reproductive and developmental toxicity; sex-hormone changes; increased urine output

Monitoring

Marker Target Why
Standardized facial photographs No established target; change from own baseline Documents wrinkle change
Skin hydration (corneometry) No established target; rise from own baseline Objective moisture change
Wrinkle severity grade Improvement of at least 1 grade Standardizes visual change
Patch test: sesquiterpene lactone mix and Compositae mix Negative Screens for daisy-family allergy
Home use test No reaction after 7 days Screens for irritation or allergy

Cadence: Baseline before starting; repeat at 2 weeks, 6–8 weeks, then every 3–6 months while use continues. No meaningful change after 8 weeks of consistent use suggests limited individual benefit.

Qualitative Assessment

  • Perceived smoothness and softness of skin around the eyes and mouth
  • Visibility of fine lines in morning light and makeup settling into lines
  • Skin comfort: absence of tightness, stinging or persistent tingling
  • Tolerability: no redness, itching, swelling or lip discomfort